Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
MEI-004 by Nanjing Minova Pharmaceutical Technology for Alopecia: Likelihood of Approval
MEI-004 is under clinical development by Nanjing Minova Pharmaceutical Technology and currently in Phase I for Alopecia. According to GlobalData,...